Introduction {#s01}
============

Cells translate physical stimuli by mechanotransduction into biochemical signals that relay information from the cell surface to the nucleus, where gene expression is regulated. Mechanotransduction controls multiple cellular aspects including, but not limited to, cell growth, shape, or differentiation ([@bib17]). Abnormal cell responses to external and internal mechanical constraints are often associated with human pathologies such as heart diseases, myopathies, and cancer ([@bib6]). The underlying mechanisms integrating mechanosensing with mechanotransduction remain poorly understood.

Caveolae are 60--80-nm bulb-like plasma membrane invaginations discovered more than 60 years ago ([@bib31]; [@bib41]). Caveolae are generated through tight association of caveolin 1 (Cav1) oligomers, its main structural component, and are stabilized by the assembly of cytoplasmic cavins into a coat-like structure around the caveolae bulb ([@bib10]; [@bib26]; [@bib38]). We established a new function of caveolae in mechanosensing and mechanoprotection in endothelial and muscle cells: under increase of membrane tension generated by cell swelling or stretching, caveolae flatten out immediately to provide additional surface area and prevent the rupture of the plasma membrane ([@bib35]). The central role of caveolae in cell mechanics has been confirmed in vivo ([@bib5]; [@bib11]; [@bib23]) and has been extended to the muscle-specific isoform Cav3 ([@bib5]; [@bib25]) and other cell types ([@bib13]; [@bib1]).

Here, we reveal that the Eps15 homology domain-containing 2 (EHD2) ATPase is released from mechanically disassembled caveolae and is subsequently translocated to the nucleus to mediate mechanotransduction through gene transcription. EHD2 is also required to maintain the caveolae reservoir at the plasma membrane under membrane tension variations. Thus, EHD2 plays a pivotal role in the cell adaptation to mechanical perturbations by connecting caveolae mechanosensing at the plasma membrane with the regulation of gene transcription.

Results and discussion {#s02}
======================

EHD2 is rapidly translocated from caveolae to the nucleus upon mechanical stress {#s03}
--------------------------------------------------------------------------------

The mechanical flattening of caveolae is immediately followed by the disassembly of caveolae and the release of caveolar proteins including Cav1 and cavins ([@bib35]; [@bib10]). We hypothesized that the release of caveolae components into the cytosol could mediate mechanotransduction events ([@bib29]; [@bib21]). We monitored the fate of cavin1 and EHD2 because these two peripheral proteins of caveolae bear nuclear localization signals and can undergo nucleocytoplasmic shuttling ([@bib32]; [@bib28]). ATP hydrolysis drives EHD2 oligomerization at the neck of caveolae, where it controls their stability through anchoring to the actin cytoskeleton ([@bib27]; [@bib37]). Cavin1/PTRF is the first identified member of the cavin family that participates in the formation of the cytoplasmic coat of caveolae ([@bib26]; [@bib19]).

Under resting conditions, EHD2 was present at the plasma membrane of HeLa cells, where it colocalized with ∼50--60% of Cav1 puncta, as previously shown (Fig. S2 A; [@bib27]; [@bib37]). As expected, a fraction of EHD2 was present in the nucleus ([Fig. 1 A](#fig1){ref-type="fig"}; [@bib32]). Repeated cycles of cell stretching and relaxation led to a moderate (≈10%), albeit significant, increase of the EHD2 signal in the nucleus. A fraction of cavin1, which bears two nuclear localization signals, was also present in the nucleus at steady state. No further increase of nuclear cavin1 was measurable upon cyclic stretch ([Fig. 1 B](#fig1){ref-type="fig"}). We also followed the intracellular fate of EHD2 under acute disassembly of caveolae induced by hypo-osmotic shock ([@bib35]). After 5 min of hypo-osmotic shock (Hypo), we measured a significantly higher (≈45%) increase in EHD2 nuclear translocation. In contrast, Cav1 was not translocated to the nucleus upon mechanical stress ([Figs. 1 C](#fig1){ref-type="fig"} and S1 A). EHD2 nuclear translocation increased with the hypo-osmotic shock strength (Fig. S1 A). We followed EHD2 dynamics in live cells in 3D with lattice light sheet microscopy ([@bib4]). During the course of the hypo-osmotic shock, the amount of nuclear EHD2 increased rapidly, reaching a plateau in ∼100 s (Fig. S1 C and Video 1). Upon return to iso-osmotic conditions, the caveolae reservoir is rapidly reassembled at the plasma membrane ([@bib35]). Under this condition (Rec), the amount of nuclear EHD2 decreased to a level slightly below steady state ([Figs. 1 C](#fig1){ref-type="fig"} and S1 A).

![**Mechanical stress induces EHD2 nuclear translocation. (A and B)** Representative wide-field immunofluorescence (left) and quantification (right) of the nuclear translocation of endogenous EHD2 (A) but not cavin1 (B) in HeLa cells after 30 min of cyclic stretch. **(C)** Representative wide-field immunofluorescence (left) and quantification (right) of endogenous EHD2 and Cav1 localization in HeLa cells under resting (Iso), after 5 min of 30 mOsm hypo-osmotic shock (Hypo), and 5 min after return to iso-osmotic conditions (Rec). **(D)** Immunoblot analysis (left) and quantification (right) of equal amounts of nuclear, cytoplasmic and cell membrane extracts after hypo-osmotic shock for the indicated times in MLEC cells having caveolae (WT) or not (Cav1^−/−^). Scale bar = 10 µm; *n* ≥ 3 independent experiments; \*, P \< 0.05; \*\*\*, P \< 0.001; \*\*\*\*, P \< 0.0001; in A and B, two-tailed *t* test; data are representative of three experiments, mean ± SEM; in C, Bonferroni's multiple comparison test; data are mean ± SEM; numbers of cells are indicated on the graphs; in D, Dunn's multiple comparison test; *n* = 3; data are mean ± SEM.](JCB_201801122_Fig1){#fig1}

We quantified the amount of endogenous EHD2 present in the nuclear, cytoplasmic, and membrane fractions of cellular protein extracts from mouse lung endothelial cells (MLECs). At steady state, EHD2 was distributed between the nuclear, cytoplasmic, and membrane fractions of MLEC WT cells having caveolae ([Fig. 1 D](#fig1){ref-type="fig"}). Hypo-osmotic shock led again to a significant increase of EHD2 nuclear content and a concomitant decrease in the membrane fractions, whereas the cytoplasmic fraction remained constant. In contrast, the initial distribution of EHD2 was not significantly changed by hypo-osmotic shock in MLEC Cav1^−/−^ cells devoid of caveolae, indicating that functional caveolae were required for EHD2 nuclear translocation induced by mechanical stress ([Fig. 1 D](#fig1){ref-type="fig"}). Similarly, a lack of EHD2-mCherry nuclear translocation was observed in HeLa Cav1^−/−^ cells (Fig. S1 B). In these cells, the amount of nuclear EHD2-mCherry was higher, suggesting that the association of EHD2 with caveolae at the plasma membrane prevents its nuclear translocation. Finally, total internal reflection microscopy (TIRF) live-cell imaging showed that dually labeled Cav1 and EHD2 puncta synchronously disappeared from the plasma membrane with the same amplitude under hypo-osmotic shock, implying that EHD2 was released during caveolae disassembly (Fig. S2 A). These observations clearly demonstrate that the mechanical disassembly of caveolae at the plasma membrane results in the translocation of EHD2 to the nucleus.

Mechanical stress results in EHD2 SUMOylation {#s04}
---------------------------------------------

We next investigated which possible posttranslational modifications of EHD2 could be associated with its mechanical release from caveolae. EHD2 was reported to be SUMOylated by SUMO1 (small ubiquitin-like modifier) on Lys^315^, which, when mutated, resulted in EHD2 nuclear accumulation ([@bib32]). Protein SUMOylation has clearly been associated with nucleocytoplasmic transport and the response to different types of stresses, including osmotic stress ([@bib12]; [@bib8]). We first explored the interaction between endogenous EHD2 and SUMO using the proximal ligation assay (PLA; [@bib36]). In Hs578T cells, which present substantial amounts of caveolae (see [Fig. 5, A--C](#fig5){ref-type="fig"}), PLA confirmed that endogenous EHD2 was SUMOylated by SUMO1 (Fig. S2 B). At steady state, a significant amount of EHD2-SUMO1 was localized in the nucleus and to a lesser extent in the cytoplasm and at the plasma membrane. Hypo-osmotic shock did not increase EHD2 SUMOylation but led to a significant relocation of EHD2-SUMO1 in the nucleus. We also analyzed the possible SUMOylation of EHD2 by SUMO2/3 and found minimal levels of EHD2-SUMO2/3 under resting conditions ([Fig. 2 A](#fig2){ref-type="fig"}). Unlike SUMO1, however, hypo-osmotic shock led to a general increase of the cellular amount of EHD2-SUMO2/3, with a significant increase in nuclear EHD2-SUMO2/3 ([Fig. 2, A and B](#fig2){ref-type="fig"}). We confirmed EHD2 SUMOylation biochemically by transfecting EHD2-GFP in HeLa cells stably expressing His-SUMO2/3. The amount of EHD2-SUMO2/3, minimal under resting conditions, increased again after hypo-osmotic shock ([Fig. 2 C](#fig2){ref-type="fig"}).

![**EHD2 is SUMOylated by SUMO2/3 upon mechanical stress. (A)** Representative wide-field fluorescence (left) and quantification (right) of in situ PLA experiments in Hs578T cells monitoring EHD2 and SUMO2/3 interaction in the whole cell (Cell), the nucleus (Nucl), and the cell minus the nucleus (Cyto + plasma membrane) under resting (Iso, *n* = 51), under hypo-osmotic (Hypo, *n* = 51), and after return to iso-osmotic (Rec, *n* = 50) conditions. **(B)** Representative z-projection (average intensity) of a confocal stack of a PLA experiment monitoring EHD2 and SUMO2/3 interaction (red signal) in MLEC cells 5 min after 30 mOsm hypo-osmotic shock. A confocal z cross section along the dashed line shows localization of PLA spots in the nucleus (DAPI; gray). **(C)** Immunoblot analysis (left) and quantification (right; SUMO2/3 level normalized to GFP) of EGFP-EHD2 SUMOylation by SUMO2/3 in immunoprecipitates from stable HeLa His-SUMO2/3 cells transfected with EHD2-EGFP or EGFP under Iso and Hypo conditions. **(D)** Same PLA experiments as in A performed in MLEC WT (Iso, *n* = 76; Hypo, *n* = 77; Rec, *n* = 72) or Cav1^−/−^ cells (Iso, *n* = 75; Hypo, *n* = 75; Rec, *n* = 75). Scale bar = 10 µm; \*, P \< 0.05; \*\*\*, P \< 0.001; \*\*\*\*, P \< 0.0001; in A and D, Dunnett's multiple comparison test, data are representative of three experiments, mean ± SEM; in C, repeated measures one-way ANOVA; data are mean ± SEM.](JCB_201801122_Fig2){#fig2}

We also measured EHD2 SUMOylation after mechanical stress release when the initial number of caveolae has fully recovered. We found a significant decrease of both EHD2-SUMO1 and EHD2-SUMO2/3, especially in the nucleus, suggesting that EHD2 deSUMOylation had occurred ([Figs. 2 A](#fig2){ref-type="fig"} and S2 B). Finally, we analyzed the EHD2 SUMOylation deficient mutant KK315-316AA, previously shown to accumulate in the nucleus, implying that EHD2-SUMOylation controlled EHD2 nuclear exit ([@bib32]). The EHD2-KK315-316AA mutant disappeared synchronously with Cav1 from the plasma membrane under hypo-osmotic shock but was unable to relocate to caveolae after shock release (Fig. S2 A). Finally, no increase in EHD2-SUMOylation was measurable in MLEC Cav1^−/−^ cells ([Fig. 2 D](#fig2){ref-type="fig"}), indicating that the pool of EHD2 that is SUMOylated under hypo-osmotic shock is the pool that was initially associated with caveolae at the plasma membrane. Together, these data show that the cycle of EHD2 SUMOylation is controlled by mechanical stress and plays a key role in the nucleocytoplasmic shuttling of EHD2.

EHD2 controls gene transcription under mechanical stress {#s05}
--------------------------------------------------------

To address the functional significance of EHD2 nuclear translocation, we used gene set enrichment analysis (GSEA; [@bib39]) to compare the transcriptome of Hs578T cells depleted or not from EHD2 and subjected to cyclic stretch for 30 min at 0.5 Hz. GSEA showed that cyclic stretching resulted in the positive enrichment of gene sets involved in hallmark signaling pathways such as TNF-α, K-Ras, and receptor interaction with the extracellular matrix ([Fig. 3 A](#fig3){ref-type="fig"}; <http://microarrays.curie.fr/>). When EHD2 was silenced, the gene set regulation observed under mechanical stress was lost. In addition, distinct gene sets related to cell cycle, cell division, and cell-cycle checkpoints were also negatively regulated. Although cyclic stretching did not result in major changes in the pattern of gene set enrichment modified by EHD2 silencing, differences in the regulation of gene sets encoding transcription factors and cell division were further shown.

![**EHD2 is required for the stabilization of caveolae and the control of gene transcription during tension variations at the plasma membrane. (A)** GSEA was performed to identify gene sets positively (+) or negatively (--) enriched by cyclic stretch in Hs578T cells depleted or not from EHD2. **(B)** Quantification of Cav1, Cav2, cavin1, cavin2, and flotillin-1 (Flot1) mRNA levels in HeLa cells transfected with control siRNA (CTRL) or siEHD2, after 30 min cyclic stretch. **(C)** Quantification of Cav1, Cav2, cavin1, and cavin2 mRNA levels in HeLa cells transfected with control siRNA (CTRL), siMOKA, or siKLF7 after 30 min cyclic stretch. **(D)** Representative TIRF images (left) and quantification (right) of changes in cell-surface Cav1 spot numbers in control siRNA (CTRL) or siEHD2-transfected Cav1-EGFP HeLa cells under resting (Iso), under hypo-osmotic (Hypo), and after return to iso-osmotic (Rec) conditions. Cells are delineated by dashes. **(E)** Quantification of changes in cell-surface endogenous Cav1 spot numbers in HeLa cells depleted (siEHD2) or not (CTRL) for EHD2 and transfected or not with EHD2-EGFP (+ EHD2) under Iso, Hypo, and Rec conditions. **(F)** Relative changes of the mean tether force under Hypo and Rec conditions in control siRNA (CTRL) and siEHD2 HeLa cells. **(G)** Quantification of cell surface Cav1 spot numbers at rest and after 30 min cyclic stretch in control siRNA (CTRL) or siEHD2 transfected HeLa cells. \*, P \< 0.05; \*\*, P \< 0.001; \*\*\*, P \< 0.001; \*\*\*\*, P \< 0.0001; two tailed *t* test. In B and C, Bonferroni's multiple comparison test; *n* = 3 independent experiments; in D--G, two-way ANOVA and Tukey's multiple comparisons test; *n* = 3; data are mean ± SEM. Numbers of cells are indicated on histogram bars. Scale bar = 10 µm.](JCB_201801122_Fig3){#fig3}

We next measured mRNA levels of caveolae constituents by reverse-transcription quantitative PCR (RT-qPCR) in HeLa cells under mechanical stress. Cyclic stretch led to a significant decrease of caveolae constituent transcripts, i.e., Cav1, Cav2, cavin1, and cavin2, without affecting transcripts of flotillin-1 (Flot1), a related membrane protein assembling microdomains distinct from caveolae at the plasma membrane ([Fig. 3 B](#fig3){ref-type="fig"}). Similar data were obtained under hypo-osmotic shock (Fig. S2 C). Importantly, no modification of transcript levels was detected in cells depleted of EHD2 ([Figs. 3 B](#fig3){ref-type="fig"} and S2 C), and a siEHD2-resistant variant fully rescued the regulation of caveolae constituent genes in EHD2-depleted cells (Fig. S2 C). The mechanical regulation of caveolae constituent gene transcription by EHD2 was no longer observed in Cav1-depleted cells, confirming that the nuclear translocation of EHD2 and its impact on gene transcription requires the disassembly of functional caveolae (Fig. S2 D). Finally, the repression activity of EHD2 on transcription was mediated by Krüppel-like factor 7 (KLF7) and modulator of KLF7 activity (MOKA; [Fig. 3 C](#fig3){ref-type="fig"}), two known partners of EHD2-regulated transcription ([@bib32]). Interestingly, KLF7 was found to bind to several enhancers of caveolae constituent genes in different cell lines (Fig. S2 E).

EHD2 stabilizes caveolae during membrane tension variations {#s06}
-----------------------------------------------------------

We next analyzed the role of EHD2 in caveolae dynamics using TIRF and found, as previously published ([@bib27]; [@bib37]; [@bib43]), that EHD2 depletion did not change the number of Cav1 spots present at the plasma membrane under resting conditions. Whereas EHD2 depletion had no effect on the extent of caveolae disassembly under hypo-osmotic shock, the reassembly of caveolae, which normally occurs immediately after the release of mechanical stress, was significantly reduced ([Fig. 3 D](#fig3){ref-type="fig"}). Expression of the dominant-negative EHD2-T72A mutant (unable to bind ATP) also reduced caveolae recovery after mechanical stress release. Conversely, expression of wild-type EHD2, EHD2-I157Q constitutively active mutant (with accelerated ATP hydrolysis), or a siEHD2-resistant variant allowed caveolae reassembly ([Figs. 3 E](#fig3){ref-type="fig"} and S3 A). Finally, depletion or overexpression of Pacsin2 and filamin A, proteins that link caveolae to the actin cytoskeleton, did not affect the reassembly of caveolae after mechanical stress release (Fig. S3, B and C).

We next examined the role of EHD2 under membrane tension variations by measuring the effective membrane tension using the tether pulling technique as described previously ([@bib33]; [@bib35]). HeLa cells were first exposed to a 5-min hypo-osmotic shock (150 mOsm) to increase membrane tension, and then to iso-osmolarity for 5 min to allow the return of membrane tension to homeostasis (Rec condition). By recording the mean variations of the tether force Δ*F* over the initial force *F~iso~* measured in isotonic conditions, we found, as expected for cells having functional caveolae ([@bib35]), that the increase of membrane tension induced by hypo-osmotic shock was buffered, as *F~hypo~* remained almost identical to *F~iso~* ([Fig. 3 F](#fig3){ref-type="fig"}). When cells were depleted of EHD2, there was a slight but not significant increase in membrane tension, in agreement with our finding that EHD2 depletion did not change the extent of caveolae disassembly induced by hypo-osmotic shock ([Fig. 3 F](#fig3){ref-type="fig"}). 5 min after return to iso-osmolarity (Rec), the membrane tension of control cells had not yet returned to the initial value measured before stress, as indicated by the negative value of the tether force Δ*F*. In EHD2-depleted cells, however, we measured a drastically smaller value of membrane tension, indicating a stronger delay in the return to membrane tension homeostasis ([Fig. 3 F](#fig3){ref-type="fig"}). We also found that repeated cycles of stretching and relaxation led to a slight but significant decrease of the number of caveolae at the plasma membrane in cells depleted of EHD2 ([Fig. 3 G](#fig3){ref-type="fig"}). Altogether, these data indicate that EHD2 is required for maintaining a functional reservoir of caveolae at the plasma membrane, which buffers the variations of membrane tension during mechanical stress.

Loss of EHD2 expression impairs caveolae mechanosensing and gene transcription {#s07}
------------------------------------------------------------------------------

Low EHD2 expression was recently reported in several solid tumors ([@bib22]; [@bib34]; [@bib42]; [@bib24]). Whether low EHD2 expression was also associated with defects in caveolae stabilization and nuclear translocation was not investigated in those studies. Given the importance of the mechanical microenvironment in tumor progression ([@bib6]) and the association of Cav1 with tumorogenesis ([@bib14]; [@bib20]), we investigated caveolae mechanics in breast cancer cell lines. We measured EHD2 mRNA levels in several normal and cancerous breast epithelial cell lines and selected Hs578T and MDA-MB-436, two triple-negative basal-like breast cancer cell lines that express high and minimal levels of EHD2 transcripts, respectively. Immunoblot analyses confirmed similar amounts of Cav1 and cavin1 proteins in Hs578T and MDA-MB-436 cells, whereas EHD2 was expressed in Hs578T but undetectable in MDA-MB-436 cells ([Fig. 4 A](#fig4){ref-type="fig"}).

![**Loss of EHD2 expression impairs caveolae mechanosensing and gene transcription in breast cancer cells. (A)** Immunoblot (left) and quantification (right) of EHD2, Cav1, and cavin1 protein levels normalized to CHC in Hs578T and MDA-MB-436 cells. **(B and C)** Representative TIRF images of changes in cell surface Cav1 spot numbers (left) and quantification (right) under resting (Iso) and hypo-osmotic (Hypo) conditions in Hs578T (B) or MDA-MB-436 (C) cells. Cells are delineated by dashes. Scale bar = 10 µm. **(D)** Quantification of changes in cell surface Cav1 spot numbers in MDA-MB-436 cells transfected or not (CTRL) with EHD2-EGFP under Iso and Hypo conditions. **(E)** Quantification of Cav1, Cav2, cavin1, and cavin2 mRNA levels in MDA-MB-436 cells transfected or not (CTRL) with EHD2 or Cav1 and in MDA-MB-436 cells depleted for Cav1 (siCav1) and transfected or not by EHD2 under hypo-osmotic conditions. **(F)** Quantification of Cav1, Cav2, cavin1, and cavin2 mRNA levels in Hs578T cells transfected with control siRNA (CTRL), siEHD2, or siCav1 after 30 min of cyclic stretch. For all panels, *n* ≥ 3 independent experiments; mRNA levels are compared with resting conditions (dotted line); \*, P \< 0.05; \*\*, P \< 0.01; \*\*\*, P \< 0.001; two tailed *t* test; data are mean ± SEM; numbers of cells are indicated on histogram bars.](JCB_201801122_Fig4){#fig4}

We first investigated the dynamics of caveolae under mechanical stress by TIRF microscopy. In agreement with the disassembly of caveolae induced by higher membrane tension, we observed a rapid and significant decrease of Cav1 spots at the cell surface of Hs578T cells after exposure to a hypo-osmotic shock ([Fig. 4 B](#fig4){ref-type="fig"}). In contrast, the number of Cav1 spots remained identical in MDA-MB-436 cells ([Fig. 4 C](#fig4){ref-type="fig"}). However, when EHD2 was expressed in MDA-MB-436 cells, a strong decrease in cell surface Cav1 spot numbers was observed again under hypo-osmotic shock ([Fig. 4 D](#fig4){ref-type="fig"}).

We next addressed whether this defect in caveolae mechanosensing was also associated with defects in gene transcription regulation. MDA-MB-436 cells did not show any variation in the level of caveolae component transcription under mechanical stress, whereas the reexpression of EHD2, but not Cav1, restored this control ([Fig. 4 E](#fig4){ref-type="fig"}). Importantly, the restoration of this control required caveolae, as it was no longer observed when EHD2-transfected MDA-MB-436 cells were depleted of Cav1 ([Fig. 4 E](#fig4){ref-type="fig"}). Whereas cyclic stretch led to a decrease of caveolae component transcripts in Hs578T cells, EHD2 depletion suppressed this control ([Fig. 4 F](#fig4){ref-type="fig"}). Similar results were observed in cells depleted of Cav1. Altogether, these data confirm that functional caveolae are required for the mechanical control of gene transcription by EHD2.

To better understand how EHD2 controls the caveolae reservoir in breast cancer cells, we analyzed the ultrastructure of caveolae on unroofed cells using metal replica EM. Consistent with high Cav1 and EHD2 expression, Hs578T cells displayed numerous budded caveolae ([Fig. 5, A--C](#fig5){ref-type="fig"}). In contrast, MDA-MB-436 cells, which lack EHD2, presented very few caveolae, if any, and most membrane invaginations were clathrin-coated pits ([Fig. 5, D--F](#fig5){ref-type="fig"}). Cav1 immunogold labeling on standard transmission electron micrographs confirmed the absence of caveolar invaginations in MDA-MB-436 cells but revealed a significant amount of Cav1 proteins present at the plasma membrane ([Fig. 5 J](#fig5){ref-type="fig"}). In contrast, Cav1 proteins were always associated with bona fide caveolar invaginations in Hs578T cells. These results most likely explain the lack of caveolae disassembly observed in MDA-MB-436 cells ([Fig. 4 C](#fig4){ref-type="fig"}), because the Cav1 signal does not correspond to caveolar invaginations but to Cav1 clusters that are unlikely to flatten out under mechanical stress. Expressing EHD2 in MDA-MB-436 cells was sufficient to reconstitute the reservoir of caveolae at the plasma membrane ([Fig. 5, G, H and I](#fig5){ref-type="fig"}). EHD2 has not been involved in caveolae assembly ([@bib27]; [@bib37]; [@bib16]); therefore, it was unexpected that MDA-MB-436 breast cancer cells do not have caveolae, because their level of Cav1 and cavin1 expression is similar to that of Hs578T cells ([Fig. 4 A](#fig4){ref-type="fig"}). Our data strongly suggest that the absence of caveolae in breast cancer cells lacking EHD2 may represent a long-term consequence of the inability to stabilize the reservoir of caveolae under the changing mechanical environment experienced by cancer cells in the tumor mass. In this context, it is interesting that a recent study showed that EHD proteins (1, 2, and 4) are functionally redundant and that only the absence of all three EHDs results in loss of caveolae under mechanical stress ([@bib43]).

![**EHD2 expression is required for the presence of caveolae at the plasma membrane of breast cancer cells. (A--I)** Survey view of the cytoplasmic surface of the plasma membrane in unroofed Hs578T cells (A--C), MDA-MB-436 (D--F) cells, and MDA-MB-436 cells transfected by EHD2-EGFP (G--I). For second inset (C, F, H, and I) use view glasses for 3D viewing of anaglyphs (left eye = red). Arrows indicate caveolae. Arrowheads indicate clathrin-coated pits. **(J)** Representative immunogold labeling of EM images of Cav1 protein localization in Hs578T and MDA-MB-436 cells. Scale bar = 200 nm. **(K)** Upon mechanical stress, Cav1, cavin1, and EHD2 are released from flattened caveolae. EHD2, but not cavin1 or Cav1, is SUMOylated and translocated to the nucleus where it controls gene transcription through interaction with MOKA and KLF-7. Upon stress release, EHD2 exits from the nucleus and is required for the stabilization of the caveolae reservoir at the plasma membrane.](JCB_201801122_Fig5){#fig5}

We and others have established caveolae as key mechanosensors ([@bib13]; [@bib35]; [@bib1]; [@bib5]; [@bib25]). We reveal here that caveolae are also mechanotransducers, and that EHD2 is central to this new function. On the one hand, we show that ATP binding to EHD2 is required for assembling and stabilizing the reservoir of caveolae at the cell surface against the variations of membrane tension induced by mechanical stress. ATP binding allows EHD2 insertion into the plasma membrane, whereas ATP hydrolysis, possibly regulated by membrane curvature, is involved in EHD2 release ([@bib16]). It is tempting to propose that caveolae flattening could trigger ATP hydrolysis by EHD2 and thereby its release from the plasma membrane. On the other hand, we show that the release of EHD2 from mechanically disassembled caveolae is rapidly followed by EHD2 nuclear translocation, where it regulates gene transcription. EHD2 SUMOylation, which is induced by mechanical stress, is a major regulator of EHD2 nucleocytoplasmic shuttling. Force-induced phosphorylation of Cav1 has been reported to regulate gene transcription of caveolae constituent biogenesis ([@bib18]). Our new results on EHD2 SUMOylation further illustrate the key role of posttranslational modifications in the caveolae response to mechanical stress. EHD2, which combines both mechanosensing and mechanotransducing activities, plays a central role in the mechanical cell response ([Fig. 5 K](#fig5){ref-type="fig"}).

Recent evidence shows that mechanical forces from both the tumor mass and its microenvironment can control cancer cells activity in vivo ([@bib6]; [@bib9]). Our study is the first report of a defect in caveolae mechanosensing and mechanotransduction in cancer cells and emphasizes the importance of revisiting the classic cellular functions of caveolae and their constituents through their new role in cell mechanics.

Materials and methods {#s08}
=====================

Antibodies and reagents {#s09}
-----------------------

The following commercially available antibodies were used for Western blotting: mouse monoclonal antibodies against clathrin heavy chain (CHC; BD Biosciences; 610500), lamin A/C (Santa Cruz Biotechnology; sc-7292), Hsp90 (Santa Cruz Biotechnology; sc-13119), EHD2 (Santa Cruz Biotechnology; sc-100724), dynamin (BD Biosciences; 610245), and filamin A (Chemicon; MAB1678); rabbit polyclonal antibodies against SUMO2/3 (Cell Signaling Technology; 4971), Cav1 (BD Biosciences; 610059), pacsin2 (Abgent; AP8088b); and cavin1 (Sigma; AV36965); for immunofluorescence, mouse monoclonal anti-cavin1 (BD Biosciences; 611258), goat polyclonal anti-EHD2 (Abcam; Ab23935), rabbit polyclonal anti-Cav1 (BD Biosciences; 610059), mouse monoclonal anti-lamin A/C (Santa Cruz Biotechnology; sc-7292), rabbit polyclonal anti-SUMO1 (Cell Signaling Technology; 4930), and rabbit polyclonal anti-SUMO2/3 (Cell Signaling Technology; 4971). Antibodies conjugated to Alexa Fluor 488, Cy3, Cy5, or HRP (Beckman Coulter and Invitrogen) were used as secondary antibodies. HaloTag dye JF635 was provided by L. Lavis (Janelia Research Campus, Howard Hughes Medical Institute, Ashburn, VA). Accutase was purchased from Sigma-Aldrich. Hepes, SDS, and Tris were purchased from Euromedex.

Plasmids {#s10}
--------

Cells were transfected using Lipofectamine 2000 (Invitrogen) according to the manufacturer's instructions. Experiments were performed 6--24 h after transfection. EHD2-mCherry, EHD2-EGFP, EHD2-I157Q-mCherry, and EHD2-T72A-mCherry were generously provided by A. Helenius (ETH Zurich, Zurich, Switzerland). EHD2-KK315-316AA-GFP was provided by M. Horowitz (Tel Aviv University, Tel Aviv, Israel). pmEmerald and Pacsin2-mCherry were purchased from Addgene. pCMV-HA-N was purchased from Clontech. EHD2-mEmerald was prepared by insertion of amplified EHD2 from EHD2-mCherry into pmEmerald plasmid using HindIII and BamHI restriction sites. Cav1-HaloTag was prepared by sequential insertion of Cav1 and HaloTag into pCMV-HA-N plasmid by EcoRI/BglII and XhoI/NotI restriction sites, respectively.

RNA interference {#s11}
----------------

Cells were transfected with siRNAs using HiPerFect (Qiagen) according to the manufacturer's instructions and cultured for 72 h. Experiments were performed upon validation of depletion efficiency with immunoblot analysis using specific antibodies and normalization to the total level of CHC used as a loading control. Control siRNA (SI03650325, 5′-AAUUCUCCGAACGUGUCACGU-3′) was purchased from Qiagen and served as a reference point. The siRNA sequences were used at the final concentration of 20 nM: siEHD2 (Qiagen; SI04205271, 5′-AGCCCUUCCGCAAACUCAATT-3′, and SI04315108, 5′-CAUCCGUCAUUCAAATT-3′), siPacsin2 (Qiagen; SI02224292, 5′-CCCUUAAUGUCCCGAGCAATT-3′, and SI02224299, 5′-AGCUUUACAUAGAACCUUATT-3′), siFilamin pool of 4 FlexiTube GeneSolution (Qiagen; GS2316, 5′-GGAAGAAGAUCCAGCAGAATT-3′, 5′-GUGGCGAUGGCAUGUACAATT-3′, 5′-GGCCCAAACUGAACCCGAATT-3′, and 5′-CAGUCAACGAGGA-3′), siMOKA (GE Dharmacon; SMARTpool: ON-TARGETplus FBXO38 \[81545\] siRNA), siKLF7 (GE Dharmacon; SMARTpool: ON-TARGETplus KLF7 \[8609\] siRNA), and siCav1 (Eurogentec; 5′-CUAAACACCUCAACGAUGA-3′, 5′-GCAUCAACUUGCAGAAAGA-3′, 5′-GCAAAUACGUAGACUCGGA-3′, and 5′-GCAGUUGUACCAUGCAUUA-3′).

Cell culture {#s12}
------------

HeLa cells, Cav1-EGFP stably transfected HeLa cells ([@bib35]), and Hs578T cells were grown at 37°C under 5% CO~2~ in DMEM GlutaMAX (GIBCO BRL Life Technologies) supplemented with 10% FCS (GIBCO BRL Life Technologies), 5 mM pyruvate (GIBCO BRL Life Technologies), and 1% penicillin-streptomycin (GIBCO BRL Life Technologies). HeLa His-SUMO2 cells were grown as HeLa cells with 1 µg/ml puromycin (InvivoGen). MLECs ([@bib35]) were maintained in EGM-2 medium (Lonza) supplemented with 15% FBS (Hyclone; GE Healthcare), 4 mM [l]{.smallcaps}-glutamine (GIBCO BRL Life Technologies), 5 mM pyruvate, and 1% penicillin-streptomycin. MDA-MB-436 cells were grown at 37°C without CO~2~ in Leibovitz's L-15 medium (GIBCO BRL Life Technologies) supplemented with 10% FCS (GIBCO BRL Life Technologies) and 1% penicillin-streptomycin (GIBCO BRL Life Technologies).

Generation of HeLa Cav1^−/−^ cells {#s13}
----------------------------------

Single guide RNA (sgRNA) designed to target exon 3 of human caveolin-1 gene was selected and analyzed using online software Benchling. The selected guide (5′-GTATTTCGTCACAGTGAAGG-3′) was inserted into pSpCas9(BB)2A-Puro plasmid, which contains SpCas9 and sgRNA scaffold (px459 v2.0, Feng Zhang laboratory, Broad Institute of MIT and Harvard, Cambridge, MA; available from Addgene as plasmid 62988). 2 µg of plasmid was transfected using a single-cuvette Nucleofector device (Lonza) as per the manufacturer's protocol. In brief, 80% confluent HeLa cells were harvested, and 10^6^ cells were resuspended in 100 µl complete solution R and transfected using Nucleofector program I-013. After transfection, cells were transferred to a 37°C, 5% CO~2~ incubator, selected for puromycin for 72 h, and sorted as single cells into 96-well plates using a MoFlo Astrios cell sorter (Beckman Coulter). After clonal expansion, protein levels of clones were evaluated by Western immunoblotting.

Cyclic stretch {#s14}
--------------

Cells were plated onto flexible-bottom plates (UniFlex plates; Flexcell International) coated with fibronectin (Sigma-Aldrich) and incubated at 37°C in a CO~2~ incubator for 24 h before applying cyclic mechanical stretch. The cells were subjected to cyclic stretch at 0.5 Hz during 30 min using a computer-controlled vacuum stretch apparatus (FX-4000T Tension Plus System; FlexCell International) with a vacuum pressure sufficient to generate 10% mechanical stretch. Replicate control samples were maintained under static conditions with no applied cyclic stretch.

Hypo-osmotic shock {#s15}
------------------

Hypo-osmotic shock was performed by diluting growth medium with deionized water (1:9 dilution for 30-mOsm hypo-osmotic shock and 1:1 for 150 mOsm hypo-osmotic shock).

Lysate preparation and immunoblot {#s16}
---------------------------------

Cells were lysed with sample buffer containing 2% SDS, 10% glycerol, 4 mM DTT, and Tris, pH 6.8. Lysates were analyzed by SDS-PAGE and immunoblotted with the indicated primary antibodies and HRP-conjugated secondary antibodies. Chemiluminescence signal was revealed using SuperSignal West Dura Extended Duration Substrate or SuperSignal West Femto Substrate (Thermo Fisher Scientific Life Technologies). Acquisition and quantification were performed on a ChemiDoc MP Imaging System (Bio-Rad).

Nuclear, cytosolic, and membrane extraction {#s17}
-------------------------------------------

Nuclear/cytoplasmic/membrane fractionation was conducted at resting conditions, at 2 and 5 min under hypo-osmotic shock (30 mOsm) as indicated, using the Subcellular Protein Fractionation Kit (Thermo Fisher Scientific) according to the manufacturer's protocol. The cytoplasmic fraction contains soluble cytoplasmic contents; the membrane fraction contains plasma, mitochondria, and ER/Golgi membranes; and the nuclear fraction contains the soluble nuclear extract and chromatin-bound nuclear proteins. Lysates were analyzed by SDS-PAGE and immunoblotted for lamin A/C as a marker of nuclear fraction, for Hsp90 as a marker of cytoplasmic fraction, and for CHC as a marker of membrane fraction. Fractions were quantified for protein content and normalized to the total cell lysate proteins.

GFP-trap {#s18}
--------

16 h after transfection, cells were treated with 100 nM leptomycin-B (Cell Signaling Technology; 9676) for 6 h. At resting conditions or after 5 min of hypo-osmotic shock, cells were harvested and lysed in 150 mM Tris-Cl, pH 6.7, 5% SDS, and 30% glycerol and then diluted 1:10 in PBS containing 0.5% NP-40 and protease inhibitor cocktail (Thermo Fisher Scientific). The lysates were then sonicated at 2× 10-s pulse (20 s in total) of 25% amplitude. Cleared lysates (13,200 rpm, 10 min, 4°C) were incubated overnight with GFPTrap-MA beads (Chromotek) at 4°C. Beads were washed three to five times with washing buffer (25 mM Tris-Cl, pH 7.4, 150 mM NaCl, 1 mM EDTA, and 5% glycerol) and eluted by boiling in 2× sample buffer at 95°C for 10 min. The eluted fractions were analyzed by Western blot and probed for GFP to determine the total EHD2-GFP pull-down level and for SUMO2/3 to measure SUMOylated EHD2.

Immunofluorescence and live-cell imaging {#s19}
----------------------------------------

Cells were fixed for 15 min at room temperature with 4% PFA in PBS. After quenching with 50 mM NH~4~Cl (Sigma-Aldrich) and permeabilization with 0.5% saponin (Sigma-Aldrich) or 1% Triton X-100, cells were blocked with 5% BSA (Sigma-Aldrich) and incubated sequentially with primary and secondary antibodies before being mounted in Fluoromount-G mounting medium (eBioscience). 2 µg/ml DAPI (Sigma-Aldrich) was used in mounting medium to counterstain nuclei. Images were acquired on a Leica DM 6000B inverted wide-field fluorescence microscope equipped with a HCX PL Apo 40× NA 1.25 oil-immersion objective and an EMCCD camera (Photometrics CoolSNAP HQ). Nuclear translocation was quantified with ImageJ software (National Institutes of Health) by calculating the nucleo-cytosolic ratio of EHD2 signal (nuclei masks were realized with the DAPI staining). TIRF images were acquired by TIRF video microscope (Nikon) equipped with a CFI Apo TIRF 100× NA 1.49 oil objective and an EMCCD camera (Photometrics HQ2). The quantification of surface Cav1 spots was realized by LabView as described in [@bib35]. In brief, caveolae were detected from TIRF images by first applying on the raw image a local intensity threshold of window size varying from 8 × 8 to 64 × 64 pixels, depending on the quality of the image. Pixels clustering together were detected as particles depending on their connectivity. Holes within particles, if any, were filled, connected particles were disconnected by eroding boundaries, and finally particles were selected by size. For colocalization, images were analyzed with ImageJ and the JACoP plugin ([@bib2]). For live imaging, cells were maintained at 37°C and under 5% CO~2~ throughout the acquisition.

Lattice light sheet microscopy (LLSM) imaging and intensity analysis {#s20}
--------------------------------------------------------------------

Cells expressing Cav1-HaloTag and EHD2-mEmerald were imaged using LLSM ([@bib4]). Image volumes of Cav1-HaloTag-- and EHD2-mEmerald--labeled cells were recorded every 2 s, using a 10-ms exposure in 30 mOsm hypo-osmotic environment for a total time of 5 min. All 3D datasets acquired were deskewed to account for the 31.8° angle of the detection objective (Nikon). After deskewing, deconvolution was performed using the Richardson--Lucy algorithm, and 4D visualization was performed using Vision 4D software (Arivis). Intensity analysis is based on a custom script written in Matlab, using Image Processing Toolbox. For the segmentation algorithm, nucleus and cell masks were defined based on Cav1 deconvolved images. The cell contour for each time point and z-plane was calculated using Otsu ([@bib30]) and Chan--Vese ([@bib3]) algorithms implemented in Matlab Image Processing Toolbox. Similar analysis was performed to estimate the nucleus contour. Intensity for each time point was calculated by integrating the defined cell and nucleus area of the deskewed images for all planes of EHD2 labeling. The ratio between nucleus and whole-cell intensity was estimated for each time point and fitted to a sigmoid equation in Prism software.

PLA {#s21}
---

The PLA kit was purchased from Sigma-Aldrich, and the assay was performed according to the manufacturer's protocol. Cells were fixed in 4% PFA for 10 min at room temperature, quenched in 50 mM NH~4~Cl for 10 min, permeabilized with 0.2% Triton X-100 (wt/vol) for 10 min, and blocked in PBS/BSA. Cells were incubated with primary antibodies for 45 min in PBS/BSA. Coverslips were mounted in Fluoromount with DAPI to stain nuclei. PLA signals were visible as fluorescent dots and imaged using wide-field fluorescence inverted microscope Leica DM 6000B equipped with a HCX PL Apo 63× NA 1.32 oil-immersion objective and an EMCCD camera (Photometrics CoolSNAP HQ). Fluorescent dots were quantified using ImageJ. Cells and nuclei were delineated to create masks. After a maximum entropy threshold, the PLA dots were quantified in both masks with the ImageJ Analyze Particles plugin. Cytoplasmic and plasma membrane values were obtained by subtracting nuclear count from the cellular count. All counts were divided by the area in pixels.

qPCR {#s22}
----

Cells were lysed using RNeasy Plus extraction kit from Qiagen at steady state or after 30 min of cyclic stretch. For hypo-osmotic shock experiments, cells were first exposed to 30 mOsm medium for 5 min, moved into iso-osmotic medium at 37°C during 1 h, and finally lysed using RNeasy Plus extraction kit. Reverse transcription reaction was performed with 1,000 ng total RNA per reaction using high-capacity cDNA reverse transcription kit (Applied Biosystems). qPCR was performed using 50 ng cDNA per 20-µl reaction. TaqMan Gene Expression Assays from Applied Biosystems were used: GAPDH (Hs02758991_g1), Cav1 (Hs00971716_m1), Cav2 (Hs00184597_m1), Cavin1 (Hs00396859_m1), Cavin2 (Hs00190538_m1), EHD2 (Hs00907482_m1), and Flot1 (Hs00195134_m1). Relative expression levels were calculated using ΔΔCT method with fold changes calculated as 2^−ΔΔCT^. GAPDH served as the internal control.

DNA microarray {#s23}
--------------

Total RNA was isolated using RNeasy Plus extraction kit after 30 min of cyclic stretch at 0.5 Hz. Gene expression profiling was performed using Affymetrix Human Gene ST 2.1 arrays. Cel files were preprocessed and annotated using the oligo and clariomshumanhttranscriptcluster.db packages. Normalization of expression across chips was performed using the RMA algorithm (rma() function from oligo package). No outlier was observed after visual inspection using the hist() and boxplot() functions. For each condition, the mean log2 fold change (logFC) compared with control was computed using the Limma R package. These logFC tables were then used to perform GSEA ([@bib39]) with default parameters using the GSEA java application (v.2.2.1) and the gene set databases available on <http://software.broadinstitute.org/gsea/msigdb/>. Analysis was performed using the GseaPreranked tool. Enrichments were considered significant if the corresponding false discovery rate (FDR; BH correction) was lower than 5%. Data description, raw data files, and tables for logFC and FDR values have been deposited on <http://microarrays.curie.fr/>.

Force measurements {#s24}
------------------

Plasma membrane tethers were extracted from cells with a bead (3 µm in diameter; Polysciences) coated with concanavalin A (Sigma-Aldrich) trapped in optical tweezers. The optical tweezers are made of a 1,064-nm laser beam (ytterbium fiber laser, λ = 1064 nm, TEM 00, 5 W; IPG Photonics) expanded and steered (optics by Elliot Scientific) in the back focal plane of the microscope objective (Apo-TIRF 100×, NA 1.45; Nikon). The whole setup was mounted on a Nikon Eclipse-Ti inverted microscope. The sample was illuminated by transmitted light, and videos were acquired at 10 Hz with an EMCCD camera (iXon 897; Andor) driven by Micro-Manager ([@bib7]). The fine movements and particularly the translational movement necessary to pull the membrane tether were performed using a custom-made stage mounted on a piezoelectric element (P753; Physik Instrumente) driven by a servo controller (E665; Physik Instrumente) and a function generator (Tektronix AFG320; Sony).

Calibration was performed using an oscillatory modulation driven by a function generator ([@bib40]) and measuring the response of the bead to an oscillatory motion of the stage. We measured *k* = 22*P* pN/(µm ⋅ W), where *P* is the laser power. This relationship is linear in the laser power range used for the experiments (0.5--2 W).

The membrane tether was held at constant length to measure the static force. For measuring membrane tension changes due to hypo-osmotic shock, the tether was held while the medium was diluted until the osmolarity reached 150 mOsm. For assessing the membrane tension change during recovery, medium osmolarity was adjusted back to 300 mOsm with 10× MEM (GIBCO BRL Life Technologies). The medium changes were performed by slowly flowing in water or 10× MEM using a 2-ml surgical syringe. The position of the beads used to compute tether forces was detected from the images using a custom ImageJ macro.

EM {#s25}
--

Cells were fixed at 37°C with 2% PFA in 0.1 M phosphate buffer. After several washes and quenching with glycine, cells were harvested in 10% gelatin, pelleted by mild centrifugation, and incubated on ice for 2 h. Afterward, pelleted cells were incubated overnight at 4°C in 2.3 M sucrose and mounted on nails in liquid nitrogen. 65-nm ultrathin cryosections were obtained using a Leica UCT ultracryomicrotome and collected on Cu/Pd-formvar-carbon--coated grids by picking up in a 1:1 mix of 2.3 M sucrose and methylcellulose. The sections were processed for immunogold labeling with an anti-Cav1 polyclonal antibody and Protein A conjugated to 10 nm gold (PAG10; <https://www.cellbiology-utrecht.nl/>) as reported previously ([@bib35]). After each labeling, grids were extensively washed with PBS and fixed again with 1% glutaraldehyde for 5 min at room temperature. Contrast was obtained by incubation with a 9:1 mix of methylcellulose and 4% uranyl acetate in water. Electron micrographs were acquired on a Tecnai Spirit electron microscope (FEI) equipped with a 4k CCD camera (EMSIS).

For unroofed metal replica EM, adherent plasma membranes from cultured cells grown on glass coverslips were disrupted by sonication as described previously ([@bib15]). Sample processing for platinum-replica EM of unroofed cells was performed as follows: glutaraldehyde/paraformaldehyde-fixed cells were further sequentially treated with osmium tetroxide, tannic acid, and uranyl acetate before ethanol dehydration and hexamethyldisilazane drying (Sigma-Aldrich). Dried samples were then rotary-shadowed with ∼2 nm platinum and 8 nm carbon. The resultant platinum replica was floated off the glass by angled immersion into hydrofluoric acid (5%), washed several times by flotation on distilled water, and picked up on 200-mesh formvar/carbon-coated EM grids. The grids were mounted in a eucentric side-entry goniometer stage of a transmission electron microscope operated at 80 kV (model CM120; Philips), replicas were viewed at ±10° tilt angles, and images were recorded with a Morada digital camera (Olympus). Images were processed in Adobe Photoshop to adjust brightness and contrast and presented in inverted contrast. Anaglyphs were made by converting the −10° tilt image to red and the +10° tilt image to cyan (blue/green), layering them on top of each other using the screen blending mode in Adobe Photoshop, and aligning them to each other.

Statistical analyses {#s26}
--------------------

All analyses were performed using GraphPad Prism v.6.0 and 7.0 for Windows (GraphPad Software). Two-tailed *t* test was used if comparing only two conditions. For comparing more than two conditions, one-way ANOVA was used with Bonferroni's multiple comparison test or Dunnett's multiple comparison test (if comparing all conditions to the control condition). Significance of mean comparison is marked on the graphs by asterisks. Error bars denote SEM or SD.

Online supplemental material {#s27}
----------------------------

Fig. S1 shows imaging and quantification of EHD2 nuclear translocation under hypo-osmotic shock. Fig. S2 shows TIRF imaging and quantification of the dynamic colocalization of Cav1 and EHD2 during osmotic shock (A), EHD2-SUMO1 interaction by PLA (B), and EHD2-dependent gene regulation under hypo-osmotic conditions (C). Fig. S3 shows TIRF imaging and quantification of Cav1 spots after hypo-osmotic shock and recovery (A--C) and RNA silencing efficiency (D). Video 1 shows LLSM imaging EHD2 nuclear translocation under hypo-osmotic shock in a HeLa cell.

Supplementary Material
======================

###### Supplemental Materials (PDF)

###### Video 1
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